Alaska Pharmacy CE Requirement 28-Hour Package
Included Courses
Courses included in this package. Click on a course to learn more.
- Addiction Medicine: Part 1: Opioids and Other Scheduled Drug Classes 2Release Date: 4/27/22
About the Course
Addiction is a brain disorder that creates a large burden on both patients and society as a whole. Pharmacists play an important role in identifying and managing patients who are at risk of abusing or addicted to opioids, stimulants, and/or benzodiazepines. Medications can assist in quitting the use of certain substances, and pharmacists are in a key position to recommend appropriate therapy based on patient factors and comorbidities. Many patients will require more than one attempt at quitting, and pharmacy professionals can offer motivation and support during this difficult time. This course will offer insight into the impact of substance use disorders in the United States and help pharmacists identify patients suffering from these diseases. After completing this course, pharmacists will have an understanding of the available treatments for addiction to opioids, stimulants, and benzodiazepines.“This course will [partially] fulfill the DEA-mandated 8 hours of training on the treatment and management of patients with opioid or other substance use disorders for DEA licensees renewing on or after June 27, 2023.” - Educating Patients: Creating Teaching Moments in Practice 4Course release date: 12/21/2022
About the Course
Effective education is essential to help patients and family gain knowledge. All healthcare professionals (HCPs) can identify teaching opportunities to assess and provide effective education. The purpose of this course is to provide HCPs with current evidence-based information to help them learn and apply skills and practice for effective patient and family teaching in a variety of settings. - Heart Failure: Evidence Review and Management 2Release Date: 8/10/2022
About the Course
Heart failure is a complex clinical syndrome associated with increasing morbidity, mortality, and economic burden. Despite evidence supporting guideline-directed therapy and management for reduction of morbidity and mortality, these medications are still underprescribed. According to the CHAMP-HF registry, among eligible patients, only 22% were prescribed essential heart failure medications per guideline recommendations ((Greene et al., 2018). Healthcare providers have an essential role in improving outcomes with heart failure by bridging the gap between guideline-directed recommendations and actual clinical practice. The learning outcomes of this activity will help clinicians understand this healthcare gap by reviewing the current evidence-based pharmacotherapy recommendations for HF treatment through analyzing clinical trials and guidelines.
- Pharmacological Management: Type 2 Diabetes in Children, 2nd Edition 3
Course release date: 1/26/2023
About the Course
This course will outline the risk factors, pathophysiology, and diagnostic criteria of type 2 diabetes. Goals of management, treatment options, and psychosocial barriers will also be addressed to guide successful multidisciplinary care of these patients. - Pharmacotherapy to Assist with Smoking Cessation 3Release Date: 1/26/2021
About the Course:
After completing this course, pharmacists will be able to help select first-line pharmacotherapy to assist smokers in quitting, educate smokers on potential adverse effects of these pharmacotherapies, and provide counseling that includes how and when to properly take the medication - The Complications of Chronic Kidney Disease, Second Edition 2
Release Date: 7/10/2023
About the Course:
This course serves as a review of chronic kidney disease (CKD) and the medications used to prevent adverse effects of CKD and slow disease progression. - The Essentials of Infection Prevention 4
Course release date: 7/10/2023
About the Course
The COVID-19 pandemic made all healthcare workers acutely aware of infection prevention and control measures. The pandemic has highlighted the need for ongoing education to maintain a knowledge and skill level appropriate for implementing strategies to prevent healthcare-associated infections and to prepare for the next pandemic. Understanding where reservoirs are harboring pathogens and strategies to prevent transmission in healthcare settings is critical. This course will examine best practices for infection prevention, such as hand hygiene, personal protective equipment, transmission-based precautions, cleaning and disinfection, and injection safety
- The Pharmacist's Role in the Opioid Crisis, 2nd Edition 6
Course Release: 1/9/2024
About the course
This course will provide pharmacists practicing in healthcare systems and community pharmacy settings an overview of contemporary considerations for ways that the opioid crisis intersects with pharmacy practice. This course will provide pharmacists with a history of the current state of the opioid crisis and how pharmacy practice has expanded to meet patient and community needs as well as ethical dimensions of the opioid crisis and the role of social determinants of health in opioid-related disparities. This course will provide pharmacists with an understanding of the disease state of opioid use disorder and how opioids affect the brain, how the pharmacist can be supportive of patients with opioid use disorder to reduce stigma and facilitate treatment-seeking, and the benefits of medications for opioid use disorder; participants will review the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain (2022 Clinical Practice Guideline).
- The Pharmacologic Management of Anxiety in Adults 2Release Date: 7/10/2023About the CourseAnxiety disorders are the most commonly diagnosed psychiatric disorders, with an estimated 264 million persons globally suffering from an anxiety disorder. It’s estimated that 19.1% of adults in the United States (U.S.) are affected by at least one anxiety disorder; this number increases to 31.9% in U.S. adolescents. Common anxiety disorders include generalized anxiety disorder (GAD), panic disorder (PD), specific phobias, agoraphobia, social anxiety disorder (SAD), and separation anxiety disorder. This course reviews the diagnosis and pharmacological management of anxiety disorders, as well as medications which can cause or exacerbate anxiety symptoms.